دورية أكاديمية
Clinical Value of Autoantibody Prognostic Markers in Tumor Immune Checkpoint Inhibitor Therapy
| العنوان: | Clinical Value of Autoantibody Prognostic Markers in Tumor Immune Checkpoint Inhibitor Therapy |
|---|---|
| المؤلفون: | Liyuan DAI, Xiaohong HAN |
| المصدر: | Chinese Journal of Lung Cancer, Vol 25, Iss 7, Pp 534-540 (2022) |
| بيانات النشر: | Chinese Anti-Cancer Association; Chinese Antituberculosis Association, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| مصطلحات موضوعية: | immune checkpoint therapy, irae, autoantibody, prognostic marker, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| الوصف: | Serum autoantibody markers have the advantages of easy specimen acquisition, simple detection technology and dynamic real-time monitoring. With the wide application of immune checkpoint inhibitors in the treatment of malignant tumors, autoantibody markers in predicting tumor immune checkpoint inhibitors efficacy and forecasting irAEs (immune related adverse events) show good prediction of potential. This review mainly focused on the progress of autoantibody markers in the prediction of therapeutic effect and the monitoring of irAE in tumor immunotherapy. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | Chinese |
| تدمد: | 1009-3419 1999-6187 |
| Relation: | https://doaj.org/toc/1009-3419; https://doaj.org/toc/1999-6187 |
| DOI: | 10.3779/j.issn.1009-3419.2022.101.28 |
| URL الوصول: | https://doaj.org/article/c1f90ff4c68747b8bc17639926ee2d24 |
| رقم الأكسشن: | edsdoj.1f90ff4c68747b8bc17639926ee2d24 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 10093419 19996187 |
|---|---|
| DOI: | 10.3779/j.issn.1009-3419.2022.101.28 |